Skip to main content
. 2024 Oct 29;14(21):2406. doi: 10.3390/diagnostics14212406

Figure 4.

Figure 4

Area under the curve (left) and normalized importance analysis (right) of ESA resistance predicting model (Legend: ESA—erythropoiesis-stimulating agents; BMI—body mass index; L-FABP—L-type fatty acid binding protein; PAI-1—plasminogen activator inhibitor-1).